Home → Focus

The Uninsured Rate Is Rising Again Print E-mail
Written by FHI's Week in Review   
Monday, 23 October 2017 11:17
Jeffrey Young reports for The Huffington Post on Oct. 20, 2017:

The national uninsured rate has started climbing back up amid higher costs for health insurance and uncertainty about the future of the Affordable Care Act, according to Gallup-Sharecare Well-Being Index survey findings released Friday. The Gallup report doesn't include data proving the causes of the uptick in the number of uninsured, but the likeliest explanation includes a mix of factors that include shortcomings of the Affordable Care Act's health insurance marketplace itself, and actions taken by President Donald Trump and the Republican-led Congress.  
Read more in the current issue of Week in Review>>
Last Updated on Saturday, 25 November 2017 13:05
Pharmacy Benefit Managers Play Significant Role in Drug Pricing Print E-mail
Written by Judi Buckalew, BSN, MPH, CAE | AAOS Now   
Monday, 23 October 2017 00:00
Congress, state legislatures, and the White House are united in a quest to reduce prices for prescription drugs. As attention focuses on pricing transparency for drugs, the role that pharmacy benefit managers (PBMs) play in the pricing process is also under scrutiny.
The complex nature of the prescription drug supply chain can be confusing, and the public may believe that drug companies are the primary cause of high drug prices. But a recent investigation by the Berkeley Research Group found that pharmaceutical manufacturers only realized 39 percent of initial gross drug expenditures (defined as "the sum of payments for prescription drugs made by patients and their health plans at the point of sale prior to any rebate, discount, or fee provided by manufacturers"), meaning that 61 percent of profits are going somewhere else.

Last Updated on Tuesday, 24 October 2017 17:56
The Drug Industry's Triumph Over the DEA Print E-mail
Written by FHI's Week in Review   
Monday, 16 October 2017 17:57

opioid-drugs-medicare Scott Higham and Lenny Bernstein report on Oct. 15, 2017:

Amid a targeted lobbying effort, Congress weakened the DEA's ability to go after drug distributors, even as opioid-related deaths continued to rise, a Washington Post and 60 Minutes investigation finds.

Read more in the current issue of Week in Review>>
Last Updated on Tuesday, 07 November 2017 20:07
'We have entered a new era': Cancer researchers no longer follow a single road to discovery Print E-mail
Written by Andrew Joseph | STAT   
Thursday, 12 October 2017 00:00
Researchers investigating cancer are no longer following a single path toward discovery, said Dr. Jeff Engelman, the vice president and global head of oncology research at Novartis. Instead, over the past five to 10 years, scientists have embarked on an array of approaches, thanks to cutting-edge discoveries that in some cases have come from other scientific fields.

Read More
Last Updated on Friday, 13 October 2017 18:40
Cancer and obesity Print E-mail
Written by FHI's Week in Review   
Monday, 09 October 2017 16:31

A Centers for Disease Control & Prevention (CDC) post dated 10/3/17 examines the relationship between cancer and obesity:

Overweight and obesity are associated with at least 13 different types of cancer. These cancers make up 40% of all cancers diagnosed. About 2 in 3 occur in adults 50-74 years old. Most types of these cancers associated with overweight and obesity increased from 2005-2014. More than half of Americans don't know that overweight and obesity can increase their risk for cancer. Many things are associated with cancer, but avoiding tobacco use and keeping a healthy weight are among the most important things people can do to lower their risk of getting cancer.
Read more in the current issue of Week in Review>>
Last Updated on Tuesday, 31 October 2017 17:16
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 5 of 117

Website design, development, and hosting provided by